{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:10:31Z","timestamp":1789391431936,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016505","name":"University of Chicago Medicine","doi-asserted-by":"publisher","award":["IRB23-0561"],"award-info":[{"award-number":["IRB23-0561"]}],"id":[{"id":"10.13039\/100016505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.modpat.2025.100770","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:13:57Z","timestamp":1744370037000},"page":"100770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Histologic Spectrum of Rituximab-Associated Common Variable Immunodeficiency-Like Enteropathy"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9830-7147","authenticated-orcid":false,"given":"Pari","family":"Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hakimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Westerhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran N.","family":"Kohnehshahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Tak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertruda","family":"Evaristo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rondell P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rish K.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela A.","family":"Salomao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Micic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E.","family":"Semrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.modpat.2025.100770_bib1","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib2","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin\u2019s lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100770_bib3","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib4","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"47","key":"10.1016\/j.modpat.2025.100770_bib6","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00277-004-0917-0","article-title":"Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells","volume":"83","author":"Stanglmaier","year":"2004","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin Hematol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100770_bib9","first-page":"676","article-title":"Mechanisms of action of CD20 antibodies","volume":"2","author":"Boross","year":"2012","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.modpat.2025.100770_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105009","article-title":"Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: pathogenesis, risk of infection, and disease management","volume":"79","author":"Alvarez","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0609.2006.00693.x","article-title":"Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma","volume":"77","author":"Nishio","year":"2006","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib12","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200211","article-title":"Multiple sclerosis, rituximab, hypogammaglobulinemia, and risk of infections","volume":"11","author":"Langer-Gould","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.modpat.2025.100770_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.11.009","article-title":"Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease","volume":"57","author":"Roberts","year":"2015","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clml.2012.11.011","article-title":"Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections","volume":"13","author":"Casulo","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaci.2021.03.041","article-title":"Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients","volume":"148","author":"Labrosse","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/qjmed\/hcu094","article-title":"Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes","volume":"107","author":"Makatsori","year":"2014","journal-title":"QJM"},{"issue":"7","key":"10.1016\/j.modpat.2025.100770_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.modpat.2025.100770_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1380654","article-title":"Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients","volume":"15","author":"Elgenidy","year":"2024","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100770_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.anai.2023.01.018","article-title":"Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab","volume":"130","author":"Athni","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2009.07715.x","article-title":"Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin","volume":"146","author":"Cooper","year":"2009","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100770_bib21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/annrheumdis-2012-201956","article-title":"Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients","volume":"72","author":"van Vollenhoven","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.modpat.2025.100770_bib22","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/acn3.51136","article-title":"Serious safety events in rituximab-treated multiple sclerosis and related disorders","volume":"7","author":"Vollmer","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/ker417","article-title":"Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics","volume":"51","author":"De La Torre","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaip.2014.06.003","article-title":"Rituximab and immune deficiency: case series and review of the literature","volume":"2","author":"Kaplan","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.modpat.2025.100770_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671503","article-title":"Rituximab associated hypogammaglobulinemia in autoimmune disease","volume":"12","author":"Tieu","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100770_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/COC.0000000000000553","article-title":"Clinical features of rituximab-associated gastrointestinal toxicities","volume":"42","author":"Mallepally","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib27","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1200\/JCO.2010.31.8899","article-title":"Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma","volume":"29","author":"Blombery","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gut.2007.138305","article-title":"Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves\u2019 disease","volume":"57","author":"El Fassi","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2025.100770_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.msard.2018.02.030","article-title":"A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review","volume":"22","author":"Shahmohammadi","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib30","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1002\/ibd.22963","article-title":"Rituximab-associated colitis","volume":"19","author":"Bhalme","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib31","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1542\/peds.2009-3395","article-title":"Severe ulcerative colitis after rituximab therapy","volume":"126","author":"Ardelean","year":"2010","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/aqab133","article-title":"Histologic findings and tissue B-cell depletion in endoscopic mucosal biopsy specimens of the gastrointestinal tract after treatment with rituximab","volume":"157","author":"Kmeid","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10620-025-08847-w","article-title":"Common variable immunodeficiency-like enteropathy associated with rituximab B-cell depletion therapy","volume":"70","author":"Hakimian","year":"2025","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib37","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q J Med"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib38","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100770_bib41","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/tropej\/fml077","article-title":"Mortality and morbidity in common variable immunodeficiency","volume":"53","author":"Aghamohammadi","year":"2007","journal-title":"J Trop Pediatr"},{"issue":"11","key":"10.1016\/j.modpat.2025.100770_bib43","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.14309\/ajg.0000000000002027","article-title":"An expert opinion\/approach: clinical presentations, diagnostic considerations, and therapeutic options for gastrointestinal manifestations of common variable immune deficiency","volume":"117","author":"Hashash","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100770_bib44","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cgh.2013.02.024","article-title":"Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency","volume":"11","author":"Agarwal","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100770_bib45","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10620-006-9736-6","article-title":"Gastrointestinal manifestations in patients with common variable immunodeficiency","volume":"52","author":"Khodadad","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1572-0241.2003.07159.x","article-title":"Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients","volume":"98","author":"Luzi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib47","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11894-004-0053-y","article-title":"Common variable immunodeficiency and the gastrointestinal tract","volume":"6","author":"Kalha","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10875-021-01104-5","article-title":"Bowel histology of CVID patients reveals distinct patterns of mucosal inflammation","volume":"42","author":"van Schewick","year":"2022","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib50","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia","volume":"20","author":"Washington","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100770_bib51","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100770_bib52","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.35.9.1244","article-title":"Studies on the enteropathy associated with primary hypogammaglobulinaemia","volume":"35","author":"Teahon","year":"1994","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1309\/AJCPEIILH2C0WFYE","article-title":"The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study","volume":"138","author":"Biagi","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100770_bib54","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/ajg.2016.329","article-title":"A cross-sectional study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency","volume":"111","author":"J\u00f8rgensen","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ibd.21376","article-title":"Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease","volume":"17","author":"Agarwal","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.1994.tb06513.x","article-title":"Intestinal B cell defects in common variable immunodeficiency","volume":"95","author":"Herbst","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13577","article-title":"Efficient long-term depletion of CD20+ B cells by rituximab does not affect gut-resident plasma cells","volume":"1415","author":"Uzzan","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12664-016-0633-4","article-title":"Association between common variable immunodeficiency and collagenous infiltrative disorders of the gastrointestinal tract: a series of four patients","volume":"35","author":"Mandaliya","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.modpat.2025.100770_bib59","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-200709002-00732","article-title":"Collagenous colitis associated with common variable immunodeficiency (abstract 732)","volume":"102","author":"Gandhi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.modpat.2025.100770_bib60","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201710001-01571","article-title":"A rare case of collagenous colitis in a patient with common variable immunodeficiency (abstract 1570)","volume":"112","author":"Sreenivasan","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2036.2011.04938.x","article-title":"Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice","volume":"35","author":"Pallav","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.modpat.2025.100770_bib62","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/gut.2008.160150","article-title":"Structural and functional changes of the duodenum in human norovirus infection","volume":"58","author":"Troeger","year":"2009","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAP.0000000000000230","article-title":"Review of drug-induced injury in mucosal biopsies from the tubular gastrointestinal tract","volume":"26","author":"Allard","year":"2019","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib64","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib65","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2004.10.048","article-title":"The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency","volume":"115","author":"Carsetti","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100770_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib67","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol"},{"issue":"26","key":"10.1016\/j.modpat.2025.100770_bib68","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1182\/blood-2011-06-361881","article-title":"B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency","volume":"118","author":"Driessen","year":"2011","journal-title":"Blood"},{"issue":"302","key":"10.1016\/j.modpat.2025.100770_bib69","doi-asserted-by":"crossref","first-page":"302ra135","DOI":"10.1126\/scitranslmed.aab1216","article-title":"IgH sequences in common variable immune deficiency reveal altered B cell development and selection","volume":"7","author":"Roskin","year":"2015","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2009.05.019","article-title":"Toll-like receptor 7 and 9 defects in common variable immunodeficiency","volume":"124","author":"Yu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100770_bib71","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2010-11-321695","article-title":"T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency","volume":"118","author":"Ochtrop","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2025.100770_bib73","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10875-014-0053-0","article-title":"Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge","volume":"34","author":"Varzaneh","year":"2014","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib74","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2249.2006.03314.x","article-title":"Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo","volume":"147","author":"Fevang","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib75","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2249.2009.03913.x","article-title":"Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency","volume":"156","author":"Horn","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100770_bib76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.modpat.2025.100770_bib77","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3389\/fimmu.2019.02753","article-title":"Current understanding and recent developments in common variable immunodeficiency associated autoimmunity","volume":"10","author":"Gereige","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.modpat.2025.100770_bib78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathmechdis-031521-024229","article-title":"Common variable immunodeficiency: more pathways than roads to Rome","volume":"18","author":"Peng","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100770_bib79","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.23473","article-title":"Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment","volume":"58","author":"Roll","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.modpat.2025.100770_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/ar2789","article-title":"Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis","volume":"11","author":"Rehnberg","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2006.08.009","article-title":"B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny","volume":"122","author":"Anolik","year":"2007","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib82","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ajg.2014.432","article-title":"The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency","volume":"110","author":"Woodward","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100770_bib83","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/phar.1509","article-title":"Ibrutinib, obinutuzumab, idelalisib, and beyond: review of novel and evolving therapies for chronic lymphocytic leukemia","volume":"34","author":"Chung","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"suppl 1","key":"10.1016\/j.modpat.2025.100770_bib84","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3816\/CLM.2004.s.003","article-title":"Radioimmunotherapy in non-Hodgkin\u2019s lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyond","volume":"5","author":"Evens","year":"2004","journal-title":"Clin Lymphoma"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib85","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000654","article-title":"Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF","volume":"7","author":"M\u00f6hn","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.modpat.2025.100770_bib86","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12288-021-01466-1","article-title":"Secondary hypogammaglobulinemia in patients with chronic lymphocytic leukemia receiving ibrutinib therapy","volume":"38","author":"\u00c7elik","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"10.1016\/j.modpat.2025.100770_bib87","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.anai.2017.10.022","article-title":"Management of hypogammaglobulinemia and recurrent infections in a chronic lymphocytic leukemia patient receiving ibrutinib","volume":"120","author":"Jiang","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl 1","key":"10.1016\/j.modpat.2025.100770_bib88","article-title":"Persistent hypogammaglobulinemia following obintuzumab treatment for chronic lymphocytic leukemia (abstract M255)","volume":"5","author":"Hauk","year":"2019","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:05:39Z","timestamp":1755695139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":88,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0893395225000663"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100770","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Histologic Spectrum of Rituximab-Associated Common Variable Immunodeficiency-Like Enteropathy","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100770"}}